MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 8 filers reported holding MONOPAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,000 | -85.7% | 2,327 | -83.0% | 0.00% | – |
Q1 2022 | $35,000 | -23.9% | 13,717 | -3.9% | 0.00% | – |
Q4 2021 | $46,000 | -32.4% | 14,275 | +2.2% | 0.00% | – |
Q3 2021 | $68,000 | -23.6% | 13,965 | -7.2% | 0.00% | – |
Q2 2021 | $89,000 | +27.1% | 15,046 | +34.0% | 0.00% | – |
Q1 2021 | $70,000 | +112.1% | 11,229 | +108.3% | 0.00% | – |
Q4 2020 | $33,000 | +135.7% | 5,391 | +99.4% | 0.00% | – |
Q3 2020 | $14,000 | -48.1% | 2,703 | -25.6% | 0.00% | – |
Q2 2020 | $27,000 | +35.0% | 3,632 | +29.5% | 0.00% | – |
Q1 2020 | $20,000 | – | 2,804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Windsor Advisory Group, LLC | 89,974 | $55,775 | 0.13% |
Rappaport Reiches Capital Management, LLC | 10,695 | $6,630 | 0.00% |
Tower Research Capital LLC (TRC) | 3,727 | $2,311 | 0.00% |
JPMORGAN CHASE & CO | 4 | $2 | 0.00% |
VANGUARD GROUP INC | 87,596 | $54,301 | 0.00% |
UBS Group AG | 72 | $45 | 0.00% |
WELLS FARGO & COMPANY/MN | 33 | $20 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 41,199 | $23,483 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 19,008 | $10,835 | 0.00% |